IndraLab

Statements


PTPN11 activates mutated EGFR. 1 / 1
| 1

reach
"Shp2 inhibition suppresses EGFR mutant induced lung adenocarcinoma by attenuating ERK1/2 and Src activation [XREF_BIBR]."